10X Genomics Inc
(TXG)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 153,104 | 141,006 | 183,979 | 153,644 | 146,819 |
| Cost of Goods | 48,884 | 48,092 | 68,197 | 58,115 | 47,207 |
| Gross Profit | 104,220 | 92,914 | 115,782 | 95,529 | 99,612 |
| Operating Expenses | 146,841 | 154,504 | 171,167 | 190,439 | 163,177 |
| Operating Income | -41,737 | -61,498 | -55,188 | -94,795 | -63,358 |
| Interest Expense | 1 | 1 | 8 | 1 | 5 |
| Other Income | 4,659 | 3,696 | 8,598 | 3,052 | 2,596 |
| Pre-tax Income | -37,079 | -57,803 | -46,598 | -91,744 | -60,767 |
| Income Tax | 818 | 2,146 | 2,354 | 1,242 | 1,647 |
| Net Income Continuous | -37,897 | -59,949 | -48,952 | -92,986 | -62,414 |
| Net Income | $-37,897 | $-59,949 | $-48,952 | $-92,986 | $-62,414 |
| EPS Basic Total Ops | -0.32 | -0.50 | -0.42 | -0.79 | -0.53 |
| EPS Basic Continuous Ops | -0.32 | -0.50 | -0.41 | -0.79 | -0.53 |
| EPS Diluted Total Ops | -0.32 | -0.50 | -0.42 | -0.79 | -0.53 |
| EPS Diluted Continuous Ops | -0.32 | -0.50 | -0.41 | -0.79 | -0.53 |
| EPS Diluted Before Non-Recurring Items | -0.32 | -0.50 | -0.41 | N/A | N/A |
| EBITDA(a) | $-30,837 | $-50,004 | $-43,482 | $-83,375 | $-51,481 |